We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Ranked Momentum Stocks to Buy for January 25th
Read MoreHide Full Article
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 25th:
CrossAmericaPartners LP (CAPL - Free Report) : This wholesale distributor of motor fuel and real estate leasing company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 100% over the last 60 days.
ABIOMED, Inc. : This developer and seller of medical devices has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.
AC Immune SA (ACIU - Free Report) : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 50.6% over the last 60 days.
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for January 25th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 25th:
CrossAmericaPartners LP (CAPL - Free Report) : This wholesale distributor of motor fuel and real estate leasing company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 100% over the last 60 days.
CrossAmerica Partners LP Price and Consensus
CrossAmerica Partners LP price-consensus-chart | CrossAmerica Partners LP Quote
CrossAmerica’s shares gained 22.2% over the last one month more than S&P 500’s gain of 7.1%. The company possesses a Momentum Score of A.
CrossAmerica Partners LP Price
CrossAmerica Partners LP price | CrossAmerica Partners LP Quote
ABIOMED, Inc. : This developer and seller of medical devices has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.
ABIOMED, Inc. Price and Consensus
ABIOMED, Inc. price-consensus-chart | ABIOMED, Inc. Quote
ABIOMED’s shares gained 13.4% over the last one month. The company possesses a Momentum Score of A.
ABIOMED, Inc. Price
ABIOMED, Inc. price | ABIOMED, Inc. Quote
AC Immune SA (ACIU - Free Report) : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 50.6% over the last 60 days.
AC Immune SA Price and Consensus
AC Immune SA price-consensus-chart | AC Immune SA Quote
AC Immune’s shares gained 7.2% over the last one month. The company possesses a Momentum Score of A.
AC Immune SA Price
AC Immune SA price | AC Immune SA Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>